(E)-hexadec-1-ene-1-sulfonic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: (E)-hexadec-1-ene-1-sulfonic acid
• 化学式: C₁₆H₃₂O₃S
• 分子量: 304.5
• InChiKey: AQAZJLHZPATQOM-FOCLMDBBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  20
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  62.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Liquid detergent composition
  申请人：AJINOMOTO CO., INC.

  公开号：EP0339498A2

  公开（公告）日：1989-11-02

  A liquid detergent composition which comprises: (A) at least one N-acylated acidic amino acid represented by general formula (I) or a salt thereof; wherein R₁ represents an alkyl group or an alkenyl group having 7 to 21 carbon atoms; M₁ and M₂ each represents hydrogen, an alkali metal or an alkanolammonium ion; and m represents an integer of 1 or 2, and (B) at least one aliphatic sulfonic acid selected from compounds represented by general formula (II) or (III) or salts thereof; R₂-CH=CH(CH₂)nSO₃M₃      (II) R₂--(CH₂)nCH₂SO₃M₃      (III) wherein R₂ represents an alkyl group having 7 to 15 carbon atoms; n represents 0 or an integer of 1 to 5; and M₃ represents hydrogen, an alkali metal or an alkanolammonium ion; wherein the ratio (A)/(B) of component (A) to component (B) is 3/7 to 7/3 by weight and the total concentration of component (A) and component (B) in the composition is in a range of 4 to 30 wt%.

  一种液体洗涤剂组合物，包括 (A) 至少一种由通式(I)代表的 N-酰化酸性氨基酸或其盐； 其中 R₁ 代表具有 7 至 21 个碳原子的烷基或烯基；M₁ 和 M₂ 各自代表氢、碱金属或烷醇铵离子；以及 m 代表 1 或 2 的整数、 (B) 至少一种脂肪族磺酸，选自通式 (II) 或 (III) 所代表的化合物或其盐； R₂-CH=CH(CH₂)nSO₃M₃ (II) R₂--(CH₂)nCH₂SO₃M₃ (III) 其中 R₂ 代表具有 7 至 15 个碳原子的烷基；n 代表 0 或 1 至 5 的整数；M₃ 代表氢、碱金属或烷醇铵离子； 其中组分（A）与组分（B）的重量比（A）/（B）为 3/7 至 7/3，组合物中组分（A）和组分（B）的总浓度为 4 至 30 wt%。
• MANUFACTURING METHOD FOR FINE ORGANIC PIGMENT
  申请人：Kao Corporation

  公开号：EP3492531A1

  公开（公告）日：2019-06-05

  The present invention relates to [1] a process for producing a fine organic pigment, including step 1 of kneading a mixture prepared by compounding a raw material organic pigment, a water-soluble inorganic salt and a water-soluble organic solvent; and step 2 of subjecting the kneaded mixture obtained in the step 1 to cleaning treatment with an aqueous solvent and then to filtration treatment, in which before or after kneading the mixture in the step 1 and before subjecting the kneaded mixture to filtration treatment in the step 2, a sulfonic acid salt dispersant is compounded in an amount of not less than 0.8 part by mass and not more than 8.0 parts by mass on the basis of 100 parts by mass of the raw material organic pigment; [2] a process for producing a dispersion, including step 3 of subjecting a pigment mixture containing the fine organic pigment obtained by the production process according to the above [1], an organic solvent and water to dispersion treatment; and [3] a process for producing an ink, including step 4 of mixing the dispersion obtained by the production process according to the above [2] with at least one medium selected from the group consisting of water and an organic solvent.

  本发明涉及[1]一种生产精细有机颜料的工艺，包括步骤 1：揉捏由有机颜料原料、水溶性无机盐和水溶性有机溶剂复配而成的混合物；步骤 2 将步骤 1 中得到的捏合混合物用水性溶剂进行清洗处理，然后进行过滤处理，其中，在步骤 1 中捏合混合物之前或之后，以及在步骤 2 中捏合混合物进行过滤处理之前，复配磺酸盐分散剂，其用量以质量份计不小于 0.8 份（按质量计）且不超过 8.0 份（按质量计）的原料有机颜料；[2]一种生产分散体的工艺，包括步骤 3，将含有通过上述[1]生产工艺获得的精细有机颜料、有机溶剂和水的颜料混合物进行分散处理；以及[3]一种生产油墨的工艺，包括步骤 4，将通过上述[2]生产工艺获得的分散体与至少一种选自水和有机溶剂的介质混合。
• DESFERRIOXAMINE-B SALTS AND THEIR USE AS ORALLY EFFECTIVE IRON CHELATORS
  申请人：CIBA-GEIGY AG

  公开号：EP0643690A1

  公开（公告）日：1995-03-22
• FORMULATIONS AND POLYMORPHIC FORMS OF DESFERRIOXAMINE AND THE PREPARATION THEREOF
  申请人：Novartis AG

  公开号：EP0944586A2

  公开（公告）日：1999-09-29
• Extracts of Curcuma and Methods of Use Thereof
  申请人：Alberte Randall S.

  公开号：US20100098788A1

  公开（公告）日：2010-04-22

  The present invention relates in part to turmeric extracts that are useful for treating or preventing neurodegenerative disorders. Another aspect of the invention relates in part to turmeric extracts that are useful for treating or preventing inflammatory disorders. In some embodiments, the extracts comprise at least one compound selected from the group consisting of 25 to 500 μg bamosamine, 25 to 750 μg echinaxanthol, 100 to 3,000 μg bisdemethoxycurcumin, 50 to 500 μg daphniyunnine E and 500 to 75,000 μg curcumin per 100 mg of extract. Another aspect of the invention relates to pharmaceutical compositions comprising the aforementioned extracts. Another aspect of the invention relates to methods of treating or preventing neurodegenerative disorders comprising administering to a subject in need thereof an effective amount of the aforementioned extracts or compositions. Another aspect of the invention relates to methods of making the aforementioned extracts.